Personalized Thera(g)nostic Approach in Patients with Pheochromocytoma and Paraganglioma: 131I-mIBG and/or Peptide Receptor Radionuclide Therapy

被引：0
|
作者：
Svirydenka, H. [1 ]
Nilica, B. [1 ]
Mair, C. [1 ]
Rossetti, L. [1 ]
Kroiss, A. [1 ]
Di Santo, G. [1 ]
Buxbaum, S. [1 ]
Decristoforo, C. [1 ]
Uprimny, C. [1 ]
Gabriel, M. [1 ]
Virgolini, I. [1 ]
机构：
[1] Univ Klin Nukl Med, Innsbruck, Austria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-563
引用
收藏
页码：S278 / S278
页数：1
相关论文
共 50 条
  • [41] A single institution experience with peptide receptor radionuclide therapy (PRRT) in advanced pheochromocytoma and paraganglioma
    Duan, H.
    Ferri, V
    Fisher, G.
    Shaheen, S.
    Davidzon, G.
    Moradi, F.
    Nguyen, J.
    Franc, B.
    Iagaru, A.
    Mari, Aparici C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 180 - 180
  • [42] 131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumours - a single-centre study
    Kotecka-Blicharz, Agnieszka
    Hasse-Lazar, Kornelia
    Handkiewicz-Junak, Daria
    Gawlik, Tomasz
    Pawlaczek, Agnieszka
    Oczko-Wojciechowska, Malgorzata
    Michalik, Barbara
    Szpak-Ulczok, Sylwia
    Krajewska, Jolanta
    Jurecka-Lubieniecka, Beata
    Jarzab, Barbara
    ENDOKRYNOLOGIA POLSKA, 2018, 69 (03) : 246 - 251
  • [43] The treatment of malignant pheochromocytoma with Iodine-131 metaiodobenzylguanidine (131I-MIBG): A comprehensive review of 116 reported patients
    Keh-Chuan Loh
    P. A. Fitzgerald
    K. K. Matthay
    P. P. B. Yeo
    D. C. Price
    Journal of Endocrinological Investigation, 1997, 20 : 648 - 658
  • [44] Combined Treatment With 131I-MIBG and Sunitinib Induces Remission in a Patient With Metastatic Paraganglioma Due to Hereditary Paraganglioma-Pheochromocytoma Syndrome From an SDHB Mutation
    Makis, William
    McCann, Karey
    McEwan, Alexander J. B.
    Sawyer, Michael B.
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (03) : 204 - 206
  • [45] Effects and safety of repeated 131I metaiodobenzylguanidine (MIBG) radiotherapy in patients with malignant pheochromocytoma and paraganglioma
    Yoshinaga, Keiichiro
    Okamoto, Shozo
    Shiga, Tohru
    Sazawa, Ataru
    Shinohara, Nobuo
    Nonomura, Katsuya
    Tamaki, Nagara
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [46] Preliminary Results of Radiation Exposure of the Relatives of Patients Undergoing 131I-MIBG Therapy
    Adamson, K. L.
    Allen, S. J.
    Clarke, S. E. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S120 - S120
  • [47] Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
    Maric, Ines
    Weber, Manuel
    Prochnow, Andre
    Schmitz, Jochen
    Unger, Nicole
    Schaarschmidt, Benedikt M.
    Poeppel, Thorsten D.
    Rischpler, Christoph
    Bockisch, Andreas
    Herrmann, Ken
    Jentzen, Walter
    Fendler, Wolfgang P.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (06) : 885 - 891
  • [48] 111In-DTPA0-octreotide (Octreoscan), 131I-MIBG and other agents for radionuclide therapy of NETs
    Jamshed B. Bomanji
    Nikolaos D. Papathanasiou
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 113 - 125
  • [49] Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
    Nastos, Konstantinos
    Cheung, Vincent T. F.
    Toumpanakis, Christos
    Navalkissoor, Shaunak
    Quigley, Anne-Marie
    Caplin, Martyn
    Khoo, Bernard
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 115 (04) : 425 - 434
  • [50] 111In-DTPA0-octreotide (Octreoscan), 131I-MIBG and other agents for radionuclide therapy of NETs
    Bomanji, Jamshed B.
    Papathanasiou, Nikolaos D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : 113 - 125
12345